Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921595875> ?p ?o ?g. }
- W2921595875 endingPage "e1623" @default.
- W2921595875 startingPage "e1610" @default.
- W2921595875 abstract "Objective To revise the 1999 Airlie House consensus guidelines for the design and implementation of preclinical therapeutic studies and clinical trials in amyotrophic lateral sclerosis (ALS). Methods A consensus committee comprising 140 key members of the international ALS community (ALS researchers, clinicians, patient representatives, research funding representatives, industry, and regulatory agencies) addressed 9 areas of need within ALS research: (1) preclinical studies; (2) biological and phenotypic heterogeneity; (3) outcome measures; (4) disease-modifying and symptomatic interventions; (5) recruitment and retention; (6) biomarkers; (7) clinical trial phases; (8) beyond traditional trial designs; and (9) statistical considerations. Assigned to 1 of 8 sections, committee members generated a draft set of guidelines based on a “background” of developing a (pre)clinical question and a “rationale” outlining the evidence and expert opinion. Following a 2-day, face-to-face workshop at the Airlie House Conference Center, a modified Delphi process was used to develop draft consensus research guidelines, which were subsequently reviewed and modified based on comments from the public. Statistical experts drafted a separate document of statistical considerations (section 9). Results In this report, we summarize 112 guidelines and their associated backgrounds and rationales. The full list of guidelines, the statistical considerations, and a glossary of terms can be found in data available from Dryad (appendices e-3–e-5, doi.org/10.5061/dryad.32q9q5d ). The authors prioritized 15 guidelines with the greatest potential to improve ALS clinical research. Conclusion The revised Airlie House ALS Clinical Trials Consensus Guidelines should serve to improve clinical trial design and accelerate the development of effective treatments for patients with ALS." @default.
- W2921595875 created "2019-03-22" @default.
- W2921595875 creator A5005793130 @default.
- W2921595875 creator A5009120301 @default.
- W2921595875 creator A5024570101 @default.
- W2921595875 creator A5026110715 @default.
- W2921595875 creator A5028975603 @default.
- W2921595875 creator A5030730290 @default.
- W2921595875 creator A5031062952 @default.
- W2921595875 creator A5032745219 @default.
- W2921595875 creator A5034922709 @default.
- W2921595875 creator A5036652104 @default.
- W2921595875 creator A5045232979 @default.
- W2921595875 creator A5049896776 @default.
- W2921595875 creator A5061914662 @default.
- W2921595875 creator A5063229609 @default.
- W2921595875 creator A5067234869 @default.
- W2921595875 creator A5067571282 @default.
- W2921595875 creator A5070593246 @default.
- W2921595875 creator A5077749574 @default.
- W2921595875 creator A5083343176 @default.
- W2921595875 creator A5084599209 @default.
- W2921595875 creator A5088547182 @default.
- W2921595875 creator A5090628289 @default.
- W2921595875 date "2019-03-08" @default.
- W2921595875 modified "2023-10-16" @default.
- W2921595875 title "Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials" @default.
- W2921595875 cites W1571682533 @default.
- W2921595875 cites W1830634249 @default.
- W2921595875 cites W1866665915 @default.
- W2921595875 cites W1885301965 @default.
- W2921595875 cites W1896896388 @default.
- W2921595875 cites W1975697525 @default.
- W2921595875 cites W1975792093 @default.
- W2921595875 cites W1980296810 @default.
- W2921595875 cites W1983207657 @default.
- W2921595875 cites W1984218351 @default.
- W2921595875 cites W1989580298 @default.
- W2921595875 cites W1992926914 @default.
- W2921595875 cites W1995838503 @default.
- W2921595875 cites W1996519676 @default.
- W2921595875 cites W2002728857 @default.
- W2921595875 cites W2010666469 @default.
- W2921595875 cites W2015852104 @default.
- W2921595875 cites W2026597231 @default.
- W2921595875 cites W2031700674 @default.
- W2921595875 cites W2037820271 @default.
- W2921595875 cites W2040937200 @default.
- W2921595875 cites W2044928246 @default.
- W2921595875 cites W2045990314 @default.
- W2921595875 cites W2060201637 @default.
- W2921595875 cites W2065965902 @default.
- W2921595875 cites W2069088496 @default.
- W2921595875 cites W2069313801 @default.
- W2921595875 cites W2071510501 @default.
- W2921595875 cites W2074842950 @default.
- W2921595875 cites W2089034809 @default.
- W2921595875 cites W2097742940 @default.
- W2921595875 cites W2104442834 @default.
- W2921595875 cites W2111377404 @default.
- W2921595875 cites W2113575093 @default.
- W2921595875 cites W2133305315 @default.
- W2921595875 cites W2140424820 @default.
- W2921595875 cites W2147662436 @default.
- W2921595875 cites W2147955864 @default.
- W2921595875 cites W2157471872 @default.
- W2921595875 cites W2163560143 @default.
- W2921595875 cites W2169984218 @default.
- W2921595875 cites W2304478657 @default.
- W2921595875 cites W2460035459 @default.
- W2921595875 cites W2520360089 @default.
- W2921595875 cites W2568175576 @default.
- W2921595875 cites W2616124858 @default.
- W2921595875 cites W2766784006 @default.
- W2921595875 cites W2794654744 @default.
- W2921595875 cites W35220292 @default.
- W2921595875 cites W4210998205 @default.
- W2921595875 doi "https://doi.org/10.1212/wnl.0000000000007242" @default.
- W2921595875 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6448453" @default.
- W2921595875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30850440" @default.
- W2921595875 hasPublicationYear "2019" @default.
- W2921595875 type Work @default.
- W2921595875 sameAs 2921595875 @default.
- W2921595875 citedByCount "99" @default.
- W2921595875 countsByYear W29215958752019 @default.
- W2921595875 countsByYear W29215958752020 @default.
- W2921595875 countsByYear W29215958752021 @default.
- W2921595875 countsByYear W29215958752022 @default.
- W2921595875 countsByYear W29215958752023 @default.
- W2921595875 crossrefType "journal-article" @default.
- W2921595875 hasAuthorship W2921595875A5005793130 @default.
- W2921595875 hasAuthorship W2921595875A5009120301 @default.
- W2921595875 hasAuthorship W2921595875A5024570101 @default.
- W2921595875 hasAuthorship W2921595875A5026110715 @default.
- W2921595875 hasAuthorship W2921595875A5028975603 @default.
- W2921595875 hasAuthorship W2921595875A5030730290 @default.
- W2921595875 hasAuthorship W2921595875A5031062952 @default.
- W2921595875 hasAuthorship W2921595875A5032745219 @default.